Breast Cancer

Top Story

Black women with breast cancer less likely to respond to neoadjuvant chemotherapy

Black women with breast cancer less likely to respond to neoadjuvant chemotherapy
February 12, 2016

Black women appeared less likely than those from other racial backgrounds to benefit from neoadjuvant chemotherapy, according to results of a database study.

In addition, black women appeared less likely to achieve pathologic complete response for triple-negative or HER-2–positive breast cancer.

In the JournalsPerspective

Genetic testing has increased in young women with breast cancer

February 12, 2016
Most young women with breast cancer appear to undergo genetic testing for mutations in the BRCA1 and BRCA2 genes, according to results of a cross-sectional analysis of…
In the Journals

Hyperthyroidism increases breast cancer risk

February 11, 2016
Women with hyperthyroidism have an increased risk for breast cancer, whereas there was a slightly decreased risk among women with hypothyroidism, according to study…
In the Journals

Survivors of adult-onset cancer experience increased CVD risk

February 9, 2016
The risk for cardiovascular disease appeared greater among adult survivors of certain cancer subtypes, including multiple myeloma, lung cancer, non-Hodgkin’s…
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Meeting News CoverageVideo

VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

August 20, 2015
More »
Featured
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
In the Journals

Black women with breast cancer less likely to respond to neoadjuvant chemotherapy

February 12, 2016
Black women appeared less likely than those from other racial backgrounds to benefit from neoadjuvant chemotherapy, according to results of a…
In the JournalsPerspective

Genetic testing has increased in young women with breast cancer

February 12, 2016
Most young women with breast cancer appear to undergo genetic testing for mutations in the BRCA1 and BRCA2 genes, according to results of a…
In the Journals

Hyperthyroidism increases breast cancer risk

February 11, 2016
Women with hyperthyroidism have an increased risk for breast cancer, whereas there was a slightly decreased risk among women with hypothyroidism…
In the Journals

Survivors of adult-onset cancer experience increased CVD risk

February 9, 2016
The risk for cardiovascular disease appeared greater among adult survivors of certain cancer subtypes, including multiple myeloma, lung cancer…
In the Journals

Breast, thyroid cancer survivors at risk for developing other malignancy

February 9, 2016
Survivors of breast cancer or thyroid cancer appeared at an increased risk for developing the other cancer as a second malignancy, according to the…

Memorial Sloan Kettering outpatient surgery facility designed to expand capacity, improve patient experience

February 9, 2016
The Josie Robertson Surgery Center opened earlier this year at Memorial Sloan Kettering Cancer Center.The facility, fully operational since Jan. 5…
In the Journals

Unprovoked VTE may increase risk for subsequent cancer diagnosis

February 9, 2016
Unprovoked venous thromboembolism appeared associated with a consistently high risk for subsequent cancer diagnosis, according to results of a…
In the JournalsPerspective

ASCO: Biomarker assays demonstrate utility for early-stage invasive breast cancer

February 8, 2016
ASCO has issued a new clinical practice guideline that endorses the use of several biomarker assays to guide decisions on adjuvant systemic therapy…
FDA News

FDA grants breakthrough therapy designation to IMMU-132 for triple-negative breast cancer

February 8, 2016
The FDA granted breakthrough therapy designation to sacituzumab govitecan for the treatment of patients with triple-negative breast cancer who have…
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping”…
More Headlines »
morganatic-roan morganatic-roan